# Levofloxacin

## Cravit IV solution 250mg/50mL

| TAH Drug Code      | [ICRA2](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ICRA2)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Respiratory tract, ENT, GUT infection. Intrauterine infections, cervicitis, uterine adnesxitis, folliculitis. GIT infections, lymphangitis, mild to moderate skin & skin tissue infections.                                                                                                                                                                                                                                                                                                                                                                 |
| Dosing             | (仿單) Adult: 250-500 mg po/IV 1-2 times daily. Administer 250 mg injection over 30 minutes, 500 mg injection over 60 minutes. (熱病) Adult: 250-750 mg po/IV Q24H (depends on indication). For most indications, in patients with normal renal function, the 750 mg dose is preferred. Pediatric (age > 28 days): 16-20 mg/kg/day (divided Q12H) (maximum 750 mg/day) For oral therapy, avoid concomitant exposure to multivalent cations (Ca, Fe, Al, Mg, Zn) in dairy products, multivitamins and antacids. Cations chelate the drug and prevent absorption. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Contraindications  | Hypersensitivity to quinolones. Pregnancy & lactation. Children & growing adolescents < 18 years. Tendinitis or tendon rupture.                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Adverse Effects    | Dizziness, GI disturbances, rash, pruritus, vaginitis, genital moniliasis, taste perversion, insomnia, tendinitis. Rarely, anaphylactic reactions, Lyell's syndrome, Stevens-Johnson's syndrome. Gastrointestinal: Diarrhea (ophthalmic, 1% to 2%; oral or intravenous, 5% ), Nausea (ophthalmic, 1% to 2%; oral or intravenous, 7% ) Neurologic: Headache (ophthalmic, 8% to 10% ; oral and intravenous, 6% )                                                                                                                                              |
| Pregnancy          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |

## Cravit F.C. 500mg

| TAH Drug Code      | [OCRA5](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OCRA5)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Respiratory tract, ENT, GUT infection. Intrauterine infections, cervicitis, uterine adnesxitis, folliculitis. GIT infections, lymphangitis, mild to moderate skin & skin tissue infections.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Dosing             | (仿單) Adult: 250-500 mg po/IV 1-2 times daily. Administer 250 mg injection over 30 minutes, 500 mg injection over 60 minutes. (熱病) Adult: 250-750 mg po/IV Q24H (depends on indication). For most indications, in patients with normal renal function, the 750 mg dose is preferred. Pediatric (age > 28 days): 16-20 mg/kg/day (divided Q12H) (maximum: 750 mg/day) For oral therapy, avoid concomitant exposure to multivalent cations (Ca, Fe, Al, Mg, Zn) in dairy products, multivitamins and antacids. Cations chelate the drug and prevent absorption.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Contraindications  | Hypersensitivity to quinolones. Epilepsy. History of tendon disorders related to fluoroquinolone administration. Children or growing adolescents. Pregnancy & lactation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Adverse Effects    | Common Gastrointestinal: Diarrhea (oral or intravenous, 5% ), Nausea (oral or intravenous, 7% ) Neurologic: Dizziness (3% ), Headache (6% to 10% ), Insomnia (4% ) Serious Cardiovascular: Aortic aneurysm, Or dissection, Cardiac arrest (0.1% to 1% ), Prolonged QT interval, Torsades de pointes, Ventricular tachycardia (0.1% to 1% ) Dermatologic: Erythema multiforme, Stevens-Johnson syndrome Endocrine metabolic: Hypoglycemia (0.1% to 1% ) Hematologic: Aplastic anemia, Pancytopenia, Thrombocytopenic purpura Hepatic: Hepatitis, Liver failure Immunologic: Hypersensitivity reaction (0.1% to 1% ), Non-allergic anaphylaxis Musculoskeletal: Myasthenia gravis, Exacerbation, Rupture of tendon, Tendinitis (0.1% to 1% ) Neurologic: Disorientated, Disturbance of attention, Guillain-Barre syndrome, Memory impairment, Peripheral neuropathy, Pseudotumor cerebri, Raised intracranial pressure, Seizure (0.1% to 1% ) Ophthalmic: Retinal detachment Psychiatric: Delirium, Depression (0.1% to 1% ), Hallucinations (0.1% to 1% ), Paranoid disorder, Psychotic disorder, Suicidal Renal: Acute renal failure (0.1% to 1% ), Tubulointerstitial nephritis |
| Pregnancy          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |

